Mastitis

09/15/2008 - "aureus becomes more common, it is likely to be a more common cause of mastitis, and antibiotics that are effective against this organism may become preferred. "
03/01/2008 - "These results indicate that Xenorhabdus antibiotics are effective against mastitis isolates and should be further evaluated for their potential in mastitis control or prevention."
04/01/2002 - "Effective treatment of Streptococcus uberis clinical mastitis to minimize the use of antibiotics."
01/01/2002 - "Antibiotics are widely used in treatment and prophylaxis of mastitis, but their antibacterial and therapeutic efficacy continues to decrease. "
01/01/1987 - "A study of the efficacy of intramammary antibiotics in the treatment of clinical mastitis."

08/01/2004 - "Ceftiofur should be effective against a wide range of contagious and environmental mastitis pathogens. "
01/01/2014 - "The objective of this study was to compare the efficacy of extended intramammary ceftiofur therapy of 8 d duration with a standard 2-day regimen for the treatment of naturally occurring mild to moderate clinical mastitis in lactating dairy cows. "
01/01/2014 - "Few studies have investigated the efficacy of extended ceftiofur therapy and none have focused on extended therapy for naturally occurring clinical mastitis. "
12/01/2011 - "The objective of this study was to evaluate the efficacy of intramammary treatment with ceftiofur hydrochloride of nonsevere, clinical coliform mastitis. "
08/01/2004 - "Objectives of the present study were to evaluate the efficacy of ceftiofur for treatment of subclinical mastitis in lactating dairy cows, and to determine if extended therapy regimens enhanced efficacy of ceftiofur. "

01/01/2003 - "Efficacy of targeted 5-day combined parenteral and intramammary treatment of clinical mastitis caused by penicillin-susceptible or penicillin-resistant Staphylococcus aureus."
10/01/1947 - "Efficacy of intramammary infusion with penicillin and diluents on streptococcic mastitis."
04/14/2009 - "The study shows that in Sweden bacteria associated with acute clinical mastitis for the most part are susceptible to antimicrobials used in therapy but resistance to penicillin in S. "
03/01/1955 - "[Puerperal mastitis in the penicillin era; studies on 1100 cases in Leipzig]."
05/01/1948 - "Acute puerperal mastitis; clinical and bacteriologic studies in relation to penicillin therapy."

08/01/1998 - "Three postmilking teat dips were tested for efficacy against Staphylococcus aureus and Streptococcus agalactiae in two separate studies using experimental challenge procedures that were recommended by the National Mastitis Council. "
11/01/1997 - "The model for the experimental challenge in the trials that were designed to test the efficacy of the two postmilking teat dips was recommended by the National Mastitis Council. "
12/01/2000 - "We tested two postmilking teat dips for efficacy against Staphylococcus aureus and Streptococcus agalactiae using experimental challenge procedures recommended by the National Mastitis Council. "
10/01/1994 - "Two postmilking teat dips were tested for efficacy against Staphylococcus aureus and Streptococcus agalactiae using experimental challenge procedures recommended by the National Mastitis Council. "
01/01/2002 - "Application of the two new postmilking teat dips was effective in reducing new IMI from contagious mastitis pathogens. "

11/01/2014 - "Efficacy of standard vs. extended intramammary cefquinome treatment of clinical mastitis in cows with persistent high somatic cell counts."
08/01/2011 - "The objectives of the present study were to evaluate the efficacy of intra-mammary-administered cefquinome for the treatment of sub-clinical mastitis in lactating dairy cows and to determine if extended therapy would enhance treatment efficacy. "
02/01/1997 - "This study supported the efficacy of cefquinome in the treatment of clinical coliform mastitis in dairy cows."
08/01/2013 - "Efficacy of extended cefquinome treatment of clinical Staphylococcus aureus mastitis."
08/01/2011 - "Efficacy of conventional and extended intra-mammary treatment of persistent sub-clinical mastitis with cefquinome in lactating dairy cows."

01/01/2015 - "Enrofloxacin concentrations were effective in the entire glandular tissue against the main pathogens causing mastitis in sheep. "
06/27/2015 - "The aim of this double-blinded field trial was to investigate the efficacy of enrofloxacin compared with placebo, with a special focus on survival, in dairy cows with acute clinical mastitis caused by E. "
06/27/2015 - "Efficacy of enrofloxacin for the treatment of acute clinical mastitis caused by Escherichia coli in dairy cows."
05/01/2010 - "Efficacy of enrofloxacin in the treatment of naturally occurring acute clinical Escherichia coli mastitis."
11/01/2000 - "coli mastitis after parturition with enrofloxacin reduced the severity of the disease, especially the decline in milk production and the changes in milk composition."

11/01/2006 - "The aim of the study was to investigate the concentrations in milk and protective effects of bovine and recombinant human lactoferrin in experimental Escherichia coli mastitis. "
04/01/2015 - "The findings indicate potential scope for incorporation of lactoferrin gene in selection and breeding of Murrah buffaloes for improved genetic resistance to mastitis. "
08/01/2004 - "The efficacy of bovine lactoferrin in the treatment of cows with experimentally induced Escherichia coli mastitis."
04/01/2015 - "The present study was undertaken with the objectives to identify allelic variants in exons 7 and 12 of lactoferrin gene and to analyze association between its genetic variants and incidence of clinical mastitis in Murrah buffalo. "
01/01/2015 - "Results from this study indicated the probable role played by Lactoferrin promoter to serve as candidate gene for mastitis susceptibility among indigenous and crossbred milch cattle. "

07/01/1978 - "VI. Comparative efficacy of a teat dip under experimental and natural exposure to mastitis pathogens."
01/01/2015 - "Considering that farmers are upgrading their local Ankole cows to cross-breed dairy cows that are more susceptible to mastitis, results from this study indicate the need to dip the teats of cows in sanitisers, improve cow hygiene, and introduce mastitis prevention and control programmes."
05/01/2010 - "These trials showed that the teat dip is able to reduce mastitis pathogens on the teats of lactating cows."
08/01/1997 - "The two trials for postmilking teat dip used a model for experimental challenge that was recommended by the National Mastitis Council. "
07/01/2006 - "The efficacies of 2 new teat dip formulations were tested against experimental challenge by contagious mastitis pathogens Staphylococcus aureus and Streptococcus agalactiae over a 12-wk period. "

03/01/1986 - "Inter-quarter evaluation clearly improved each indirect mastitis parameter; NAGase and antitrypsin were better indicators of differences between infected and non-infected quarters than BSA or the somatic cell count."
11/01/1997 - "This study examined the capability of milk somatic cell count (SCC) and NAGase activity to discriminate between quarters that had been cured versus those that had not been cured at 4 wk after antimicrobial therapy for clinical mastitis. "
05/01/1991 - "This study examined effects of repeated episodes of clinical mastitis in chronically infected quarters on milk N-acetyl-beta-D-glucosaminidase activity and duration of clinical signs. "
07/01/1987 - "Studies on induced Klebsiella mastitis with relationships among N-acetyl-beta-D-glucosaminidase, bacterial and somatic cell counts."
06/01/2013 - "Milk APP concentrations and NAGase activity in clinical mastitis caused by different udder pathogens were studied. "

11/01/1993 - "These vaccines doubtless will prove beneficial on well managed dairies that have eradicated contagious mastitis pathogens. "
08/01/2014 - "Results support the continued study of mastitis vaccines for use in managing staphylococcal mastitis and SCC in dairy goats. "
12/15/2014 - "Commercially available vaccines for mastitis control are composed either of S. "
02/01/2014 - "Commercially available vaccines for mastitis control are composed either of S. "
01/01/2013 - "All the strains possessed the pilus island 2b (PI-2b) gene and the prevalent capsular genotypes were types Ia (89% isolates) and II (11% isolates), the conserved pilus type providing suitable data for the development of vaccines against mastitis caused by S. "

12/01/2004 - "Based on the widespread use of homeopathy in treatment of animal disease and the poor documentation of its possible effects and consequences, a clinical trial was carried out in order to evaluate the efficacy of homeopathy in treatment of clinical mastitis in dairy cows and a design for clinical studies on homeopathic treatment, taking into account the guidelines for randomized-clinical trials (RCT) as well as the basic principles of homeopathy. "
11/01/2010 - "In cases of pathogen-positive mastitis (n=91), the cure rate after 4 and 8 weeks was similar between the two treatment strategies, homeopathy and antibiotic treatment, but the difference between the homeopathic and the placebo treatment at day 56 was significant (P<0·05). "
04/01/2010 - "A randomized controlled trial to compare the use of homeopathy and internal Teat Sealers for the prevention of mastitis in organically farmed dairy cows during the dry period and 100 days post-calving."
12/01/2004 - "Comparison of homeopathy, placebo and antibiotic treatment of clinical mastitis in dairy cows - methodological issues and results from a randomized-clinical trial."
04/01/2002 - "Those levels were: 1) symptom level (seriousness of the mastitis case), 2) cow level (to the extent a cow fulfilled goals of the farmer and the herd), 3) herd level (the situation of the herd, e.g., in relation to milk quota), and 4) level of alternatives (whether the farmer regards such practices as blinding of teats or homoeopathy as serious alternatives to antibiotic treatment). "

08/01/2002 - "Results of the present study demonstrated that microsphere have the potential for new intramammary disinfectant formulations that can provide increased efficacy of therapy against mastitis pathogens."
06/01/2010 - "The aim of this study was to evaluate the effects of preparation method and the type of surfactant on the properties of cephalexin (CPX) microspheres in order to obtain delivery systems suitable for the treatment of dairy mastitis. "
01/01/2009 - "The aim of this study was to evaluate the effects of emulsion type and process parameters on the properties of CPX-loaded PLGA microspheres in order to obtain delivery systems suitable for the treatment of dairy mastitis. "
06/15/2013 - "A microbead carrying specific anti-mastitis bacteria antibodies and an enhancer of phagocytosis, termed Y-complex, was tested in two experiments. "
06/01/2010 - "Cephalexin microspheres for dairy mastitis: effect of preparation method and surfactant type on physicochemical properties of the microspheres."

07/01/2011 - "The objectives of this study were to characterize 60-d outcomes after treatment of mild (abnormal milk) and moderate (abnormal milk and abnormal udder) cases of clinical mastitis (CM) occurring in a single quarter of cows on Wisconsin farms (n=4) and to determine risk factors associated with those outcomes. "
02/01/2015 - "These results suggest that LF concentration decreased with decrease in SCC after treatment and that LAP concentration and LPO activity differed depending on the severity of mastitis. "
09/01/2014 - "Duplicate milk samples were collected from the affected quarter for microbiological analysis at the onset of clinical mastitis and 14 to 21 d after treatment ended. "
01/01/2014 - "Duration of clinical mastitis after treatment in early lactation was less than late lactation in the first-parity cows (p = 0.005). "
05/01/2013 - "Treatment was applied every 12 hours for 3 days and cows were evaluated for clinical cure starting on day 4. Outcomes of interest consisted of mastitis resolution at day 4, time to resolution, somatic cell score (SCS) after recovery, and bacteriological cure at 14 and 28 d after treatment. "

08/01/2002 - "Different methods of immunomodulation for the prevention of mastitis have shown promise in experimental trials, but the evidence is not yet enough to support commercial applications. "
05/01/2006 - "It should then be possible to enhance the resistance of dairy ruminants to mastitis through immunomodulation and genetic improvement."
05/01/2002 - "Regulation of adhesion molecules on circulating neutrophils during coliform mastitis and their possible immunomodulation with drugs."
01/01/1998 - "An understanding of its role will be of help in designing strategies for immunomodulatory therapies for mastitis."
01/01/2015 - "Sampling of the teat canal led to the isolation of 165 isolates, among which a selection of ten non-redundant LAB strains belonging to the genera Lactobacillus and Lactococcus were further characterized with regard to several properties: surface properties (hydrophobicity, autoaggregation); inhibition potential of three main mastitis pathogens, Staphylococcus aureus, Escherichia coli and Streptococcus uberis; colonization capacities of bovine mammary epithelial cells (bMEC); and immunomodulation properties. "

01/01/2003 - "The research on reproduction which has been going on during the past ten years in the department of Obstetrics, Reproduction and Herd Health, has been mainly concerned with: Embryo transplantation, in vitro fertilisation and ovum pick up The evaluation of sperm quality Improved freezing methods for both sperm and embryo's The development of new insemination techniques The composition of a new diluent for fresh sperm Cystic ovarian follicles in cows Subfertility in different species of animals Next to the above mentioned study fields, the department is also involved in the research into swine fever, respiratory diseases in pigs, antibiotic resistance in pigs and cattle, mastitis and metabolic problems in cattle and salmonella infections in pigs."